The safety of drugs for the treatment of nausea and vomiting of pregnancy

Bibliography

• NGUYEN P, EINARSON A: Managing nausea and vomiting of pregnancy with pharmacological and nonpharmacological treatments. Fut. Med. (2006) 2:753-760.
   Google Scholar
• VELLACOTT I, COOKE E, JAMES E: Nausea and vomiting in early pregnancy. Int. J. Gynaecol. Obstet. (1988) 27:57-62.
   PubMed Web of Science ®Google Scholar
• MILLER F: Nausea and vomiting in pregnancy: the problem of perception – is it really a disease? Am. J. Obstet. Gynecol. (2002) 186:S182-S183.
   PubMed Web of Science ®Google Scholar
• SHERMAN P, FLAXMAN S: Nausea and vomiting of pregnancy in an evolutionary perspective. Am. J. Obstet. Gynecol. (2002) 186:S190-S197.
   PubMed Web of Science ®Google Scholar
• ATTARD C, KOHLI M, COLEMAN S et al.: The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am. J. Obstet. Gynecol. (2002) 186:S220-S227.
   PubMed Web of Science ®Google Scholar
• BADELL M, RAMIN S, SMITH J: Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy (2006) 26:1273-1287.
   PubMed Web of Science ®Google Scholar
• PIWKO C, UNGAR W, EINARSON T, WOLPIN J, KOREN G: The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto motherisk program. Curr. Med. Res. Opin. (2007) 23:833-840.
   PubMed Web of Science ®Google Scholar
• BASHIRI A, NEWMANN L, MAYMON E, KATZ M: Hyperemesis gravidarum: epidemiological features, complications and outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. (1995) 63:135-138.
   PubMed Web of Science ®Google Scholar
• ELIAKIM R, OVADIA A, SHERER D: Hyperemesis gravidarum: a current review. Am. J. Perinat. (2000) 17:207-218.
   PubMed Web of Science ®Google Scholar
• DEPUE R, BERNSTEIN L, ROSS R, JUDD H, HENDERSON B: Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiology study. Am. J. Obstet. Gynecol. (1987) 156:1137-1141.
   PubMed Web of Science ®Google Scholar
• HAYAKAWA S, NAKAJIMA N, KARASAKI-SUZUKI M et al.: Frequent presence of Helicobacter pylori genome in the saliva of patients with Hyperemesis gravidarum. Am. J. Perinat. (2000) 17:243-247.
   PubMed Web of Science ®Google Scholar
• FRIGO P, LANG C, REISENBERGER K, KÖLBL H, HIRSCHL A: Hyperemesis gravidarum associated with Helicobacter pylori seropositivity. Obstet. Gynecol. (1998) 91:615-617.
   PubMed Web of Science ®Google Scholar
• JACOBY E, PORTER K: Helicobacter pylori infection and persistent Hyperemesis gravidarum. Am. J. Perinat. (1999) 16:85-88.
   PubMed Web of Science ®Google Scholar
• VERBERG M, GILLIOT D, AL-FARDAN N, GRUDZINSKAS J: Hyperemesis gravidarum, a literature review. Hum. Reprod. Update (2005) 11:527-539.
   PubMed Web of Science ®Google Scholar
• DAVIS M: Nausea and vomiting of pregnancy: an evidence-based review. J. Perinat. Neonat. Nurs. (2004) 18:312-328.
   PubMed Web of Science ®Google Scholar
• HOD M, ORVIETO R, KAPLAN B, FRIEDMAN S, OVADIA J: Hyperemesis gravidarum: a review. J. Reprod. Med. (1994) 39:605-612.
   PubMed Web of Science ®Google Scholar
• KOCH K: Gastrointestinal factors in nausea and vomiting of pregnancy. Am. J. Obstet. Gynecol. (2002) 186:S198-S203.
   Google Scholar
• KOCH K: Review article: clinical approaches to unexplained nausea and vomiting. Adv. Gastroenterol. Hepatol. Clin. Nutr. (1998) 3:163-178.
   Google Scholar
• LOUIK C, HERNANDEZ-DIAZ S, WERLER M, MITCHELL A: Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr. Perinat. Epidemiol. (2006) 20:270-278.
   PubMed Web of Science ®Google Scholar
• KOREN G, PAIRAUDEAU N: Compliance with prenatal vitamins. Patients with morning sickness sometimes find it difficult. Can. Fam. Phys. (2006) 52:1392-1393.
   PubMed Web of Science ®Google Scholar
• CHANDRA K, MAGEE L, EINARSON A, KOREN G: Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. J. Psychosom. Obstet. Gynaecol. (2003) 24:71-75.
   PubMed Web of Science ®Google Scholar
• JEWELL D, YOUNG G: Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst. Rev. (2003) 4:CD000145.
   PubMedGoogle Scholar
• LEVICHEK Z, ATANACKOVIC G, OEPKES D et al.: Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can. Fam. Phys. (2002) 48:267-277.
   PubMed Web of Science ®Google Scholar
• BISHAI R, MAZZOTTA P, ATANACKOVIC G et al.: Critical appraisal of drug therapy for nausea and vomiting of pregnancy. II. Efficacy and safety of diclectin (doxylamine-B6). Can. J. Clin. Pharmacol. (2000) 7:138-143.
   PubMedGoogle Scholar
• BOSKOVIC R, EINARSON A, MALTEPE C, WOLPIN J, KOREN G: Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J. Obstet. Gynaecol. Can. (2003) 25:830-833.
   PubMedGoogle Scholar
• ATANACKOVIC Z, NAVIOZ Y, MORETTI M, KOREN G: The safety of higher than standard dose of doxylamine–pyridoxine (diclectin) for nausea and vomiting of pregnancy. J. Clin. Pharmacol. (2001) 41:842-845.
   PubMed Web of Science ®Google Scholar
• BRENT R: The Bendectin Saga: another American tragedy. Teratology (1983) 27:283-286.
   PubMedGoogle Scholar
• EINARSON T, LEEDER J, KOREN G: A method for meta-analysis of epidemiological studies. Drug Intell. Clin. Pharm. (1988) 22:813-824.
   PubMedGoogle Scholar
• MCKEIGUE P, LAMM S, LINN S, KUTCHER J: Bendectin and birth defects. I. A meta-analysis of the epidemiologic studies. Teratology (1994) 50:27-37.
   PubMedGoogle Scholar
• CARTWRIGHT E: Dramamine in nausea and vomiting of pregnancy. West J. Surg. (1951) 59:216-234.
   PubMedGoogle Scholar
• KING A: The treatment of nausea and vomiting with a pill. Obstet. Gynecol. (1955) 6:332-338.
   PubMed Web of Science ®Google Scholar
• MCCOLL J, GLOBUS M, ROBINSON S: Effect of some therapeutic agents in the developing rat fetus. Toxicol. Appl. Pharmacol. (1965) 7:409-417.
   PubMed Web of Science ®Google Scholar
• SCAHTZ M, PETITTI D: Anti-histamines and pregnancy. Ann. Allergy Ashthma Immunol. (1997) 78:157-159.
   PubMed Web of Science ®Google Scholar
• MELLIN G, KATZENSTEIN M: Meclozine and foetal abnormalities. Lancet (1963) 1:222-223.
   PubMed Web of Science ®Google Scholar
• BRIGGS G, FREEMAN R, YAFFE S (Eds): Drugs in Pregnancy and Lactation. (5th Edition). Williams and Wilkins, Baltimore, USA (1998).
   Google Scholar
• HEINONEN O, SLONE D, SHAPIRO S (Eds): Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton, MA, USA (1977).
   Google Scholar
• MICHAELIS J, MICHAELIS H, GLUCK E, KOLLER S: Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology (1983) 27:57-64.
   PubMedGoogle Scholar
• SETO A, EINARSON T, KOREN G: Pregnancy outcome following first trimester exposure to antihistamine medications: a meta-analysis. Am. J. Perinatol. (1997) 14:119-124.
   PubMed Web of Science ®Google Scholar
• MOSER J, CALDWELL J, RHULE F: No more than necessary: safety and efficacy of low-dose promethazine. Ann. Pharmacother. (2006) 40:45-48.
   PubMed Web of Science ®Google Scholar
• KOUSSEN M: Treatment of nausea and vomiting in pregnancy. Am. Fam. Phys. (1993) 48:1279-1284.
   PubMed Web of Science ®Google Scholar
• KING C, WEAVER S, NARROD S: Antihistamines and teratogenicity in the rat. J. Pharmacol. Exp. Ther. (1965) 147:391-398.
   PubMed Web of Science ®Google Scholar
• POTTS C, ULLERY J: Maternal and fetal effects of obstetric analgesia. Am. J. Obstet. Gynecol. (1961) 81:1252-1259.
   Google Scholar
• CZEIZEL A, SZEGAL B, JOFFE J: The effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspring. Neurotoxicol. Teratol. (1999) 21:157-167.
   PubMed Web of Science ®Google Scholar
• WALKER B, PATTERSON A: Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology (1974) 10:159-164.
   PubMedGoogle Scholar
• HANNAH R, ROTH S, SPIRA A: The effects of chlorpromazine and phenobarbital on vasculogenesis in the cerebellar cortex. Acta Neuropathol. (Berlin) (1982) 57:306-308.
   PubMed Web of Science ®Google Scholar
• FARKAS V, FARKAS G: Teratogenic action of hyperemesis in pregnancy and of medication used to treat it. Zentralbl Gynakol (1971) 10:325-330.
   Google Scholar
• Micromedex® Healthcare Series. ReproTox®.
   Google Scholar
• AUERBACH J, HANS S, MARCUS J, MAEIR S: Maternal psychotropic medication and neonatal behavior. Neurotoxicol. Teratol. (1992) 14:399-406.
   PubMed Web of Science ®Google Scholar
• O'CONNOR M, JOHNSON G, JAMES D: Intrauterine effect of phenothiazines. Med. J. Aust. (1981) 1:416-417.
   PubMed Web of Science ®Google Scholar
• SZABO K, BRENT R: Species differences in experimental teratogenesis by tranquillizing agents. Lancet (1974) 1:565.
   PubMedGoogle Scholar
• ROUX C: Action teratogene de la prochlopemazine. Arch. Fr. Pediatr. (1959) 6:968-971.
   Google Scholar
• HO C: Congenital malformations. Cleft palate, congenital heart disease, absent tibiae, and polydactyly. Am. J. Dis. Child (1975) 129:714-716.
   PubMedGoogle Scholar
• FREEMAN R: Limb deformities: possible association with drugs. Med. J. Aust. (1972) 1:606-607.
   PubMed Web of Science ®Google Scholar
• RAFLA N: Limb deformities associated with prochlorperazine. Am. J. Obstet. Gynecol. (1987) 156:1557-1559.
   PubMedGoogle Scholar
• NELSON M, FORFAR J: Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. BMJ (1971) 1:523-527.
   PubMed Web of Science ®Google Scholar
• SLONE D: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol. (1977) 128:486-488.
   PubMed Web of Science ®Google Scholar
• KULLANDER S, KALLEN B: A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet. Gynecol. Scand. (1976) 55:105-111.
   PubMed Web of Science ®Google Scholar
• MILKOVICH L, VAN DEN BERG B: An evaluation of the teratogenicity of certain antinauseant drugs. Am. J. Obstet. Gynecol. (1976) 125:244-248.
   PubMed Web of Science ®Google Scholar
• RIEDER R, ROSENTHAL D, WENDER P, BLUMENTHAL H: The offspring of schizophrenics. Fetal and neonatal deaths. Arch. Gen. Psychiatry (1975) 32:200-211.
   PubMed Web of Science ®Google Scholar
• WATANABE N: Teratogenicity of metoclopramide. Yakugaku Kenkyu (1968) 39:92-106.
   Google Scholar
• Product information. Reglan® (1997).
   Google Scholar
• SORENSON H, NIELSON G, CHRISTENSON K, TAGE-JENSEN U, EKBORN A, BARON J; THE EUROMAP STUDY GROUP: Birth outcome following maternal use of metoclopramide. Br. J. Clin. Pharm. (2000) 343:264-268.
   Google Scholar
• BERKOVICH M, ELBRIT D, ADDIS A, SCHULER-FACCINI L, ORNOY A: Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N. Engl. J. Med. (2000) 343:445-446.
   PubMedGoogle Scholar
• Product information. Zofran® (1997).
   Google Scholar
• TUCKER M, JAAKSON M, SCALES M: Ondansetron: pre-clinical safety evaluation. Eur. J. Clin. Oncol. (1989) 25:S79-S93.
   PubMedGoogle Scholar
• GUIKONTES E, SPANTIDEAS A, DIANKAKIS J: Ondansetron and Hyperemesis gravidarum. Lancet (1992) 340:1223-1238.
   PubMed Web of Science ®Google Scholar
• WORLD M: Ondansetron and Hyperemesis gravidarum. Lancet (1993) 341:185-189.
   PubMed Web of Science ®Google Scholar
• TINCELLO D, JOHNSON M: Treatment of Hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad. Med. J. (1996) 72:688-689.
   PubMed Web of Science ®Google Scholar
• SULLIVAN C, JOHNSON C, ROACH H, MARTIN R, STEWART D, MORRISON J: A pilot study of intravenous ondansetron for Hyperemesis gravidarum. Am. J. Obstet. Gynecol. (1996) 174:1565-1568.
   PubMed Web of Science ®Google Scholar
• ASKER C, NORSTEDT W, KALLEN B: Use of antiemetic drugs during pregnancy in Sweden. Eur. J. Clin. Pharmacol. (2005) 61:899-906.
   PubMed Web of Science ®Google Scholar
• EINARSON A, MALTEPE C, NAVIOZ Y, KENNEDY D, TAN M, KOREN G: The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. Br. J. Obstet. Gynaecol. (2004) 111:940-943.
   Google Scholar
• MAZZOTTA P, MAGEE L: A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs (2000) 59:781-800.
   PubMed Web of Science ®Google Scholar
• MAGEE L, MAZZOTTA P, KOREN G: Evidence-based view of safety and effectiveness of pharmacological therapy for nausea and vomiting of pregnancy (NVP). Am. J. Obstet. Gynecol. (2002) 186:S256-S261.
   PubMed Web of Science ®Google Scholar
• EINARSON A, KOREN G, BERGMAN U: The treatment of nausea and vomiting in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. (1998) 76:103-106.
   Google Scholar